Kura Oncology Inc (KURA)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current KURA market cap is 1.61B. The company's latest EPS is USD -2.0035 and P/E is -10.53.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -36.57M | -40M | -42.47M | -46.76M | -54.45M |
| Net Income | -34.07M | -37.17M | -38.6M | -42.79M | -49.53M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -67.48M | -91.9M | -131.26M | -139.87M | -165.8M |
| Net Income | -63.14M | -89.63M | -130.47M | -135.84M | -152.63M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 425.98M | 494.74M | 473.77M | 448.94M | 553.91M |
| Total Liabilities | 30.79M | 35.06M | 43.83M | 51.66M | 48.82M |
| Total Equity | 395.18M | 459.68M | 429.94M | 397.27M | 505.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 241.97M | 647.21M | 534.05M | 456.31M | 448.94M |
| Total Liabilities | 23.19M | 36.31M | 27.44M | 36.03M | 51.66M |
| Total Equity | 218.78M | 610.91M | 506.61M | 420.28M | 397.27M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -35.87M | -61.49M | -90.52M | -124.82M | -48.84M |
| Investing | 11.13M | -35.2M | -26.64M | 15.56M | -95.34M |
| Financing | N/A | 94.01M | 94.09M | 94.78M | 148.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -54.76M | -69.83M | -104.55M | -110.06M | -124.82M |
| Investing | -46.33M | -99.94M | -126.84M | 32.63M | 15.56M |
| Financing | 111.1M | 469.33M | -3.44M | 38.57M | 94.78M |
| Market Cap | 1.61B |
| Price to Earnings Ratio | -10.53 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 43.05 |
| Price to Book Ratio | 4.04 |
| Dividend Yield | - |
| Shares Outstanding | 76.18M |
| Average Volume (1 week) | 1.09M |
| Average Volume (1 Month) | 731.33k |
| 52 Week Change | 108.19% |
| 52 Week High | 24.17 |
| 52 Week Low | 7.41 |
| Spread (Intraday) | 2.03 (9.23%) |
| Company Name | Kura Oncology Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.kuraoncology.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
